In this work the syntheses of novel bis(eta5-cyclopentadienyl)(2,3-quinoxaline-dithiolato)titanium(IV) derivatives and bis(eta5-cyclopentadienyl)(1-phenyl)(2-methyl)(1,2-ethenedithiolato)titanium(IV) is described.
Lena J.C. de, Garner C.D.
doaj
A new class of anti-proliferative activity and apoptotic inducer with molecular docking studies for a novel of 1,3-dithiolo[4,5-b]quinoxaline derivatives hybrid with a sulfonamide moiety. [PDF]
Ismail MA +4 more
europepmc +1 more source
In the field of organic solar cells, organic semiconductors with Y6‐based chemical structure and their corresponding quinoxaline‐based assemblies are settled down as promising materials in the field of OSCs.
Fátima Suárez‐Blas +11 more
doaj +1 more source
Human Enterovirus B: Selective Inhibition by Quinoxaline Derivatives and Bioinformatic RNA-Motif Identification as New Targets. [PDF]
Madeddu S +11 more
europepmc +1 more source
A Convenient Way to Quinoxaline Derivatives through the Reaction of 2-(3-Oxoindolin-2-yl)-2-phenylacetonitriles with Benzene-1,2-diamines. [PDF]
Aksenov AV +8 more
europepmc +1 more source
Biological activity of new quinoxaline derivatives
A.A. Zubenko +5 more
openaire +1 more source
In this study, a novel series of 1,2,4-triazolo[4,3-a]quinoxalines containing a sulfonamide moiety was designed and synthesized through regioselective synthesis from 2 and/ 3-hydrazino-6-(pyrrolidin-1-ylsulfonyl)quinoxaline derivatives 5 and 7.
Moustafa S. Abusaif +7 more
doaj +1 more source
Characterization of quinoxaline derivatives for protection against iatrogenically induced hearing loss. [PDF]
Zallocchi M +6 more
europepmc +1 more source
Novel quinoxaline derivatives as dual EGFR and COX-2 inhibitors: synthesis, molecular docking and biological evaluation as potential anticancer and anti-inflammatory agents. [PDF]
Ahmed EA, Mohamed MFA, Omran OA.
europepmc +1 more source
Design and Synthesis of New Quinoxaline Derivatives as Potential Histone Deacetylase Inhibitors Targeting Hepatocellular Carcinoma: In Silico, In Vitro, and SAR Studies. [PDF]
Ma C +7 more
europepmc +1 more source

